Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
申请人:——
公开号:US20030087917A1
公开(公告)日:2003-05-08
The present invention relates to the use of at least one compound of the general formula I,
L-D-B-G (I)
in which L and G are aromatic, optionally heterocyclic radicals, D is an aliphatic or heteroaliphatic connecting link and B is a 6-, 7- or 8-membered saturated or unsaturated ring bonded to D via the 1 position and to G via the 4 or 5 position and having one or two nitrogen heteroatoms, for the treatment of disorders of the central nervous system and in particular of disorders which are to be assigned to the psychiatric or neurological type. These compounds offer particular advantages in the control of addiction.
本发明涉及至少一种通式为 I 的化合物的用途、
L-D-B-G (I)
其中 L 和 G 是芳香基,可选杂环基,D 是脂肪族或杂脂族连接基,B 是 6、7 或 8 元饱和或不饱和环,通过 1 位与 D 键合,通过 4 或 5 位与 G 键合,具有一个或两个氮杂原子,用于治疗中枢神经系统疾病,特别是精神或神经类型的疾病。这些化合物在控制成瘾方面具有特别的优势。